Zellwerk Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

Zellwerk General Information

Description

Developer of medical of technologies designed to offer cell culture, biopharmaceutical processing and tissue engineering. The company's technologies contains rotary-bed bioreactors for the cultivation of cell lines and primary cells, enabling researchers to cultivate adherently growing mammalian cells, recombinant glycoproteins and develop a variety of implants inexpensively in regenerative medicine.

Contact Information

Formerly Known As
Gene Tools GmbH
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Ziegeleistrasse 7
  • Oberkrämer
  • 16727 Eichstadt
  • Germany
+49 03304
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • Ziegeleistrasse 7
  • Oberkrämer
  • 16727 Eichstadt
  • Germany
+49 03304

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zellwerk Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-May-2021 Completed Generating Revenue
2. Secondary Transaction - Private 01-Jan-2003 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Zellwerk’s complete valuation and funding history, request access »

Zellwerk Patents

Zellwerk Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102023002417-B3 Method for expanding cells Active 15-Jun-2023
DE-102023002232-B3 Perfusion plate meander bioreactor for cell expansion Active 01-Jun-2023
DE-102022000456-B3 Plate meander bioreactor for the isolation and propagation of cells, especially adherently growing mesenchymal stoma cells Active 05-Feb-2022
AU-2021447912-A1 Method for producing tumor-infiltrating t-lymphocytes (til) and their use as cellular therapeutics for the treatment of human tumors Pending 27-May-2021
CA-3218528-A1 Method for producing tumor-infiltrating t-lymphocytes (til) and their use as cellular therapeutics for the treatment of human tumors Pending 27-May-2021 C12N5/0636
To view Zellwerk’s complete patent history, request access »

Zellwerk Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zellwerk FAQs

  • When was Zellwerk founded?

    Zellwerk was founded in 1997.

  • Where is Zellwerk headquartered?

    Zellwerk is headquartered in Eichstadt, Germany.

  • What is the size of Zellwerk?

    Zellwerk has 10 total employees.

  • What industry is Zellwerk in?

    Zellwerk’s primary industry is Biotechnology.

  • Is Zellwerk a private or public company?

    Zellwerk is a Private company.

  • What is Zellwerk’s current revenue?

    The current revenue for Zellwerk is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process